Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease

Plasma tryptase elevation during aspirin-induced respiratory reactions occurs in 50% of reactions despite CysLT1R antagonist prophylaxis and identifies lung function decline and extra-respiratory symptoms in aspirin-exacerbated respiratory disease (AERD).